GO
Loading...

US Democrats ask Gilead about pricing

Friday, 21 Mar 2014 | 12:30 PM ET

CNBC's Sheila Dharmarajan reports on the decline in the Nasdaq because of the hit to the biotechs. Gilead received a letter from senior Democrats requesting a briefing on the pricing for its hepatitis C drug Sovaldi.